Joseph Wagner

Keine laufenden Positionen mehr

59 Jahre

Health Technology

Consumer Services

Profil

Joseph P.
Wagner served as Chief Executive Officer at Insight Molecular Diagnostics, Inc. Served as President, Chief Executive Officer & Director at BriaCell Therapeutics Corp.
from 2015 to 2016.
Served as Executive Director at University of California Drug Discovery Consortium.
Served as Vice President-Cellular Therapy at Neuronyx, Inc. Served as President at Cell Targeting, Inc. Served as Chief Scientific Officer at Notable Labs Ltd. from 2020 to 2024.
Education includes undergraduate studies at Rochester Christian University and a doctorate from Duke University School of Medicine.

Ehemalige bekannte Positionen von Joseph Wagner

Unternehmen	Position	Ende
BRIACELL THERAPEUTICS CORP.	Vorstandsvorsitzender	24.03.2016
Neuronyx, Inc. Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells	Corporate Officer/Principal	13.10.2009
University of California Drug Discovery Consortium	Direktor/Vorstandsmitglied	-
Cell Targeting, Inc. Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions	Präsident	-

Sehen Sie sich die Erfahrung von Joseph Wagner im Detail an

Ausbildung von Joseph Wagner

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Joseph Wagner im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	7
Rochester Christian University Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Neuronyx, Inc. Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells	Health Technology
Cell Targeting, Inc. Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions	Health Technology
OncoCyte Corp. OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer	Health Technology
Duke University School of Medicine Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BriaCell Therapeutics Corp. BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer	Health Technology
University of California Drug Discovery Consortium